---
figid: PMC4073973__cmar-6-279Fig3
figtitle: PD-1/PD-L1 immune checkpoint pathway
organisms:
- Homo sapiens
- Diaporthe sclerotioides
organisms_ner:
- Homo sapiens
pmcid: PMC4073973
filename: cmar-6-279Fig3.jpg
figlink: /pmc/articles/PMC4073973/figure/f3-cmar-6-279/
number: F3
caption: 'PD-1/PD-L1 immune checkpoint pathway. PD-L1 is expressed on antigen-presenting
  cells whereas PD-1 is expressed on T-lymphocytes. The PD-1–PD-L1 pathway impairs
  the ability of T-lymphocytes to mount an immune response. This is a key checkpoint
  in a normal immune response.Abbreviation: APC, antigen-presenting cells.'
papertitle: 'Update on benefit of immunotherapy and targeted therapy in melanoma:
  the changing landscape.'
reftext: Neeharika Srivastava, et al. Cancer Manag Res. 2014;6:279-289.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8142977
figid_alias: PMC4073973__F3
figtype: Figure
redirect_from: /figures/PMC4073973__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4073973__cmar-6-279Fig3.html
  '@type': Dataset
  description: 'PD-1/PD-L1 immune checkpoint pathway. PD-L1 is expressed on antigen-presenting
    cells whereas PD-1 is expressed on T-lymphocytes. The PD-1–PD-L1 pathway impairs
    the ability of T-lymphocytes to mount an immune response. This is a key checkpoint
    in a normal immune response.Abbreviation: APC, antigen-presenting cells.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD80
  - CD28
  - CD86
  - APC
  - PROC
  - CD274
  - PDCD1
  - RPL17
  - RPL17-C18orf32
---
